Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Merck
Chubb
Covington
Citi
Cipla

Generated: July 15, 2019

DrugPatentWatch Database Preview

Patent: 8,333,963

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,333,963
Title:Method of inhibiting osteoclast activity
Abstract: Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
Inventor(s): Anderson; Dirk M (Port Townsend, WA), Galibert; Laurent J (Prevessin Moens, FR)
Assignee: Immunex Corporation (Thousand Oaks, CA)
Application Number:12/850,368
Patent Claims:see list of patent claims

Details for Patent 8,333,963

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen XGEVA denosumab INJECTABLE; SUBCUTANEOUS 125320 002 2010-06-01 ➤ Sign Up Immunex Corporation (Thousand Oaks, CA) ➤ Sign Up RX Orphan company
Amgen PROLIA denosumab INJECTABLE; SUBCUTANEOUS 125320 001 2010-06-01 ➤ Sign Up Immunex Corporation (Thousand Oaks, CA) ➤ Sign Up RX Orphan company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,333,963

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 9828424 Jul 02, 1998
World Intellectual Property Organization (WIPO) 9828424 Sep 11, 1998
World Intellectual Property Organization (WIPO) 9828426 Jul 02, 1998
World Intellectual Property Organization (WIPO) 9958674 Feb 10, 2000
World Intellectual Property Organization (WIPO) 9958674 Nov 18, 1999
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
Daiichi Sankyo
Harvard Business School
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.